Intraoperative floppy iris syndrome in a patient taking alfuzosin for benign prostatic hypertrophy

Intraoperative floppy-iris syndrome.

OBJECTIVE Intraoperative-floppy iris syndrome (IFIS) has been recently described. It has been demonstrated that this new syndrome complicates cataract surgery. In this paper we have reviewed the syndrome, and offer practical information specially related to the origin and management of this syndrome and we offer practical information. MATERIAL AND METHODS A review of the related medical liter...

The Intraoperative Floppy Iris Syndrome

A t the annual meeting of the ASCRS in April, John R. Campbell, MD, and I reported on two companion studies that we conducted to examine the incidence, characteristics, surgical outcomes, and etiology of floppy irides during cataract surgery.1,2 We named this condition the intraoperative floppy iris syndrome (IFIS) (Figures 1 to 3). Based upon retrospective observations by Dr. Campbell regardin...

Prospective masked comparison of intraoperative floppy iris syndrome severity with tamsulosin versus alfuzosin.

OBJECTIVE To determine whether severe intraoperative floppy iris syndrome (IFIS) is more or equally likely with tamsulosin or alfuzosin. DESIGN Prospective, masked, multicenter, cross-sectional study. PARTICIPANTS AND CONTROLS Consecutive patients taking systemic tamsulosin or alfuzosin and scheduled for routine cataract surgery (case group) and patients with no history of systemic α1-antag...

Silodosin-associated intraoperative floppy iris syndrome

intraoperative floppy iris Syndrome : update 2012

α-BlOcKeRS anD iFiS Tamsulosin was reportedly introduced in Japan in 1993, in the United Kingdom in 1997, and in the United States in 1997. Gupta et al related the popularity of the drug to its high affinity for the α1A receptor, which explains the lower incidence of adverse cardiovascular events in patients taking tamsulosin compared with less selective α-adrenergic blockers.3 Additionally, th...